KURA logo

Kura Oncology (KURA) Free Cash Flow

Annual FCF

$133.84 M
+$258.84 M+207.08%

December 31, 2024

Summary

Performance

1-Year Change

+207.08%

3-Year Change

+226.63%

5-Year Change

+344.42%

15-Year Change

+570.61%

KURA Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

88.95%
KURA annual free cash flow is higher than 88.95% of companies in Healthcare sector

High & Low

All-time High

$133.84 M
KURA annual free cash flow is currently at an all-time high

3-Year Low

-$124.99 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2024
KURA previous annual earnings announcement was published on Dec 31, 2024

Next Annual Earnings Report Date

N/A
KURA next annual earnings announcement has not yet been scheduled

OtherKURAcash flowmetrics:

Annual CFO

$134.32 M
KURA annual cash flow from operations is $134.32 million

Annual CFF

$154.42 M
KURA annual cash flow from financing activities is $154.42 million

Annual CFI

-$101.59 M
KURA annual cash flow from investing activities is -$101.59 million

Annual CAPEX

$472.00 K
KURA annual capital expenditures is $472.00 thousand

Quarterly FCF

$268.76 M
+$312.20 M+718.69%

December 31, 2024

Summary

Performance

3-Month Change

+718.69%

1-Year Change

+883.01%

3-Year Change

+883.01%

5-Year Change

+883.01%

KURA Quarterly FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

95.23%
KURA quarterly free cash flow is higher than 95.23% of companies in Healthcare sector

High & Low

All-time High

$268.76 M
KURA quarterly free cash flow is currently at an all-time high

3-Year Low

-$48.93 M

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
KURA previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

May 2, 2025
KURA next earnings announcement is scheduled for May 2, 2025

OtherKURAcash flowmetrics:

Quarterly CFO

$269.13 M
KURA quarterly cash flow from operations is $269.13 million

Quarterly CFF

$806.00 K
KURA quarterly cash flow from financing activities is $806.00 thousand

Quarterly CFI

-$94.95 M
KURA quarterly cash flow from investing activities is -$94.95 million

Quarterly CAPEX

$372.00 K
KURA quarterly capital expenditures is $372.00 thousand

TTM FCF

$133.84 M
+$303.08 M+179.09%

December 31, 2024

Summary

Performance

3-Month Change

+179.09%

1-Year Change

+207.08%

3-Year Change

+207.08%

5-Year Change

+207.08%

KURA TTM FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

88.87%
KURA TTM free cash flow is higher than 88.87% of companies in Healthcare sector

High & Low

All-time High

$133.84 M
KURA TTM free cash flow is currently at an all-time high

3-Year Low

-$169.24 M

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
KURA previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

May 2, 2025
KURA next earnings announcement is scheduled for May 2, 2025

OtherKURAcash flowmetrics:

TTM CFO

$134.32 M
KURA TTM cash flow from operations is $134.32 million

TTM CFF

$154.42 M
KURA TTM cash flow from financing activities is $154.42 million

TTM CFI

-$101.59 M
KURA TTM cash flow from investing activities is -$101.59 million

TTM CAPEX

$372.00 K
KURA TTM capital expenditures is $372.00 thousand

Free Cash Flow Formula

FCF = Cash From Operations − CAPEX

Annual FCF

$133.84 M
KURA annual free cash flow is $133.84 million

Annual CFO

$134.32 M
KURA annual cash flow from operations is $134.32 million

Annual CAPEX

$472.00 K
KURA annual capital expenditures is $472.00 thousand

KURA Free Cash Flow Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+207.1%+883.0%+207.1%
3 y3 years+226.6%+883.0%+207.1%
5 y5 years+344.4%+883.0%+207.1%

KURA Free Cash Flow Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+207.1%at high+649.3%at high+179.1%
5 y5-yearat high+207.1%at high+649.3%at high+179.1%
alltimeall timeat high+207.1%at high+649.3%at high+179.1%

Kura Oncology Free Cash Flow History

DateAnnualQuarterlyTTM
Dec 2024
$133.84 M(-207.1%)
$268.76 M(-718.7%)
$133.84 M(-179.1%)
Sep 2024
-
-$43.44 M(+2.1%)
-$169.24 M(+9.3%)
Jun 2024
-
-$42.55 M(-13.0%)
-$154.84 M(+12.2%)
Mar 2024
-
-$48.93 M(+42.5%)
-$138.01 M(+10.4%)
Dec 2023
-$124.99 M(+12.9%)
-$34.32 M(+18.2%)
-$124.99 M(+6.6%)
Sep 2023
-
-$29.05 M(+13.0%)
-$117.21 M(+7.0%)
Jun 2023
-
-$25.71 M(-28.4%)
-$109.55 M(-4.2%)
Mar 2023
-
-$35.91 M(+35.3%)
-$114.37 M(+3.3%)
Dec 2022
-$110.69 M(+4.7%)
-$26.54 M(+24.1%)
-$110.69 M(+2.9%)
Sep 2022
-
-$21.39 M(-29.9%)
-$107.61 M(-3.5%)
Jun 2022
-
-$30.52 M(-5.3%)
-$111.54 M(+2.0%)
Mar 2022
-
-$32.23 M(+37.3%)
-$109.38 M(+3.5%)
Dec 2021
-$105.70 M(+46.8%)
-$23.47 M(-7.3%)
-$105.70 M(+4.8%)
Sep 2021
-
-$25.32 M(-10.7%)
-$100.81 M(+8.3%)
Jun 2021
-
-$28.36 M(-0.6%)
-$93.13 M(+16.1%)
Mar 2021
-
-$28.55 M(+53.6%)
-$80.22 M(+11.4%)
Dec 2020
-$72.00 M(+31.5%)
-$18.58 M(+5.4%)
-$72.00 M(+6.9%)
Sep 2020
-
-$17.63 M(+14.1%)
-$67.35 M(+8.9%)
Jun 2020
-
-$15.45 M(-24.0%)
-$61.87 M(+1.7%)
Mar 2020
-
-$20.33 M(+45.9%)
-$60.84 M(+11.1%)
DateAnnualQuarterlyTTM
Dec 2019
-$54.76 M(+12.5%)
-$13.93 M(+14.7%)
-$54.76 M(+7.3%)
Sep 2019
-
-$12.14 M(-15.8%)
-$51.04 M(-1.6%)
Jun 2019
-
-$14.43 M(+1.3%)
-$51.89 M(+3.7%)
Mar 2019
-
-$14.25 M(+39.6%)
-$50.05 M(+2.9%)
Dec 2018
-$48.66 M(+71.1%)
-$10.21 M(-21.5%)
-$48.66 M(+6.0%)
Sep 2018
-
-$13.00 M(+3.2%)
-$45.92 M(+17.3%)
Jun 2018
-
-$12.59 M(-2.0%)
-$39.15 M(+19.8%)
Mar 2018
-
-$12.85 M(+71.9%)
-$32.67 M(+14.9%)
Dec 2017
-$28.44 M(+12.2%)
-$7.47 M(+19.9%)
-$28.44 M(+2.7%)
Sep 2017
-
-$6.24 M(+2.0%)
-$27.70 M(+2.8%)
Jun 2017
-
-$6.11 M(-29.1%)
-$26.94 M(+1.1%)
Mar 2017
-
-$8.62 M(+28.0%)
-$26.66 M(+5.2%)
Dec 2016
-$25.35 M(+40.9%)
-$6.74 M(+23.1%)
-$25.35 M(+4.6%)
Sep 2016
-
-$5.47 M(-6.1%)
-$24.23 M(+4.4%)
Jun 2016
-
-$5.83 M(-20.4%)
-$23.21 M(+9.6%)
Mar 2016
-
-$7.31 M(+30.1%)
-$21.17 M(+17.7%)
Dec 2015
-$17.99 M
-$5.62 M(+26.2%)
-$17.99 M(+45.4%)
Sep 2015
-
-$4.45 M(+17.7%)
-$12.37 M(+56.2%)
Jun 2015
-
-$3.78 M(-8.4%)
-$7.92 M(+91.6%)
Mar 2015
-
-$4.13 M
-$4.13 M

FAQ

  • What is Kura Oncology annual free cash flow?
  • What is the all time high annual FCF for Kura Oncology?
  • What is Kura Oncology annual FCF year-on-year change?
  • What is Kura Oncology quarterly free cash flow?
  • What is the all time high quarterly FCF for Kura Oncology?
  • What is Kura Oncology quarterly FCF year-on-year change?
  • What is Kura Oncology TTM free cash flow?
  • What is the all time high TTM FCF for Kura Oncology?
  • What is Kura Oncology TTM FCF year-on-year change?

What is Kura Oncology annual free cash flow?

The current annual FCF of KURA is $133.84 M

What is the all time high annual FCF for Kura Oncology?

Kura Oncology all-time high annual free cash flow is $133.84 M

What is Kura Oncology annual FCF year-on-year change?

Over the past year, KURA annual free cash flow has changed by +$258.84 M (+207.08%)

What is Kura Oncology quarterly free cash flow?

The current quarterly FCF of KURA is $268.76 M

What is the all time high quarterly FCF for Kura Oncology?

Kura Oncology all-time high quarterly free cash flow is $268.76 M

What is Kura Oncology quarterly FCF year-on-year change?

Over the past year, KURA quarterly free cash flow has changed by +$303.08 M (+883.01%)

What is Kura Oncology TTM free cash flow?

The current TTM FCF of KURA is $133.84 M

What is the all time high TTM FCF for Kura Oncology?

Kura Oncology all-time high TTM free cash flow is $133.84 M

What is Kura Oncology TTM FCF year-on-year change?

Over the past year, KURA TTM free cash flow has changed by +$258.84 M (+207.08%)